TY - JOUR
T1 - A Glimpse into Uveitis in the Aging Eye
T2 - Pathophysiology, Clinical Presentation and Treatment Considerations
AU - Akinsoji, Elizabeth
AU - Goldhardt, Raquel
AU - Galor, Anat
PY - 2018/4/16
Y1 - 2018/4/16
N2 - Uveitis describes a group of inflammatory conditions of the eye that have various underlying causes and clinical presentations. Susceptibilities to uveitis in the elderly may be attributed to age-related risk factors such as immunosenescence, increased immunological inflammatory mediators, and autoimmunity. Overall, anterior uveitis is more common than posterior and panuveitis in the general population and also in the elderly. Some causes of uveitis in the elderly are herpes simplex virus, ocular ischemic syndrome, sarcoidosis, and central nervous system lymphoma, and these will be discussed in detail herein. Eye care professionals need to consider the wide differential for uveitis, obtain the appropriate history, conduct a detailed clinical examination, and tailor management to the clinical presentation and underlying cause of disease. The challenges of polypharmacy and nonadherence in the elderly impact patient outcomes and must be taken into consideration when considering treatment.
AB - Uveitis describes a group of inflammatory conditions of the eye that have various underlying causes and clinical presentations. Susceptibilities to uveitis in the elderly may be attributed to age-related risk factors such as immunosenescence, increased immunological inflammatory mediators, and autoimmunity. Overall, anterior uveitis is more common than posterior and panuveitis in the general population and also in the elderly. Some causes of uveitis in the elderly are herpes simplex virus, ocular ischemic syndrome, sarcoidosis, and central nervous system lymphoma, and these will be discussed in detail herein. Eye care professionals need to consider the wide differential for uveitis, obtain the appropriate history, conduct a detailed clinical examination, and tailor management to the clinical presentation and underlying cause of disease. The challenges of polypharmacy and nonadherence in the elderly impact patient outcomes and must be taken into consideration when considering treatment.
UR - http://www.scopus.com/inward/record.url?scp=85045451697&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045451697&partnerID=8YFLogxK
U2 - 10.1007/s40266-018-0545-3
DO - 10.1007/s40266-018-0545-3
M3 - Article
C2 - 29663152
AN - SCOPUS:85045451697
SP - 1
EP - 10
JO - Drugs and Aging
JF - Drugs and Aging
SN - 1170-229X
ER -